Hans H Sonneborn

Title: The Innovations of Hans H. Sonneborn

Introduction

Hans H. Sonneborn is a notable inventor based in Heusenstamm, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic and diagnostic preparations. With a total of 4 patents, his work has had a considerable impact on medical science.

Latest Patents

Sonneborn's latest patents include innovative uses of tetrahydrobiopterin to enhance the proliferative activity of lymphokines and other cell growth factors. His research indicates that adding pterins to lymphokines can increase their activity by 3 to 5 times. Another significant patent involves the creation of monoclonal antibodies that recognize a structure common to human interleukin-2 and the light chain of human immunoglobulin. This process involves immunizing animals, particularly mice, with human interleukin-2 and fusing the splenocytes with myeloma cells to create hybridomas. The antibodies produced are then tested for specificity to human interleukin-2.

Career Highlights

Throughout his career, Sonneborn has worked with various organizations, including Biotest Serum Institut GmbH and Gesellschaft für Strahlen- und Umweltforschung mbH. His expertise in biotechnology has allowed him to contribute to advancements in medical research and therapeutic applications.

Collaborations

Sonneborn has collaborated with notable colleagues such as Udo Schwulera and Hans D. Hempel. These partnerships have further enriched his research and development efforts in the field.

Conclusion

Hans H. Sonneborn's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and therapeutic innovations.